Alcyone Therapeutics
Sanchita Bhatnagar is on the Board of Advisors at Alcyone Therapeutics. Sanchita is also the Assistant Professor, Biochemistry & Molecular Genetics at University of Virginia.
This person is not in the org chart
This person is not in any offices
Alcyone Therapeutics
Alcyone Therapeutics is a biotechnology company pioneering next-generation precision central nervous system (CNS) therapies to improve the lives of patients and families impacted by severe neurological conditions. Alcyone Therapeutics is advancing a pipeline of adeno-associated virus (AAV) gene therapy programs that leverage its proprietary, next-generation CNS delivery technology platform. Alcyone Therapeutics’ lead programs target the treatment of Rett syndrome and spinal muscular atrophy with respiratory distress type 1 (SMARD1).